New York State Common Retirement Fund Talaris Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$1.78 - $3.2 $25,988 - $46,720	-14,600 Reduced 98.65%	200 $1,000
Q3 2022 Nov 08, 2022	BUY	$2.3 - $5.03 $131 - $286	57 Added 0.39%	14,800 $39,000
Q2 2022 Aug 04, 2022	SELL	$4.51 - $9.85 $230 - $502	-51 Reduced 0.34%	14,743 $66,000
Q1 2022 May 05, 2022	BUY	$6.89 - $16.56 $31,728 - $76,258	4,605 Added 45.2%	14,794 $146,000
Q4 2021 Feb 02, 2022	BUY	$12.18 - $17.0 $30,450 - $42,500	2,500 Added 32.51%	10,189 $156,000
Q3 2021 Nov 02, 2021	BUY	$11.61 - $15.99 $1,033 - $1,423	89 Added 1.17%	7,689 $104,000
Q2 2021 Aug 02, 2021	BUY	$12.25 - $18.61 $93,100 - $141,436	7,600 New	7,600 $112,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.